Certificate number:RU.77.99.88.003.Е.005168.12.17
Date of registration and renewal:04.12.2017
Dosage form: & nbspTablets weighing 375 mg.
Classification "Composition" & nbsp Dietary supplements - proteins, amino acids and their derivatives BAD - vitamin and mineral complexes BAD - products of plant, animal or mineral origin
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing silicon Supplements containing calcium and phosphorus Supplements containing potassium and magnesium
Composition: & nbspMicrocrystalline cellulose carrier, fish extract Biomarine Complex®, starch, sodium L-ascorbate (vitamin C), zinc gluconate (zinc), amorphous silicon dioxide antioxidant agents and magnesium stearate, pectin stabilizer.
Scope: & nbspDFor realization to the population as a biologically active additive to food - an additional source of vitamin C and zinc.
Suggested Usage: & nbspAT2 tablets, with water, once a day, with food intake. Duration of admission - 4 weeks.
Contraindications:ANDindividual intolerance of components, pregnancy, breast-feeding.
Special instructions: Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in a dry, cool place protected from light, at a temperature not exceeding + 25 ° С.
Research protocols:ATreplacing the certificate of state registration No. RU.77.99.88.003.Е.005058.11.17 of 24.11.2017, the expert opinions of the FGBICU "NII Nutrition" №72 / Э-212 / б-15 of 22.11.2015, FGBUN " FIC Nutrition and Biotechnology "No. 529 / E-748 / b-17 of 07/09/2017.
Recipient:Pfizer Innovations, LLCPfizer Innovations, LLC Russian Federation
Information update date: & nbsp01.02.2018
Instructions
Up